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Abstract: We present a case of nephron sparing surgery (NSS),of a patient,68 years olld, resident
in e Prizren, who had a tumor bigger than 7 (8.5 cm), meaning T2a staging tumor.Renal cell
carcinoma (RCC) is a common malignancy with an increasing incidence1. NSS was proven
feasible decades ago for patients with imperative indications to preserve maximum kidney
function, for instance solitary kidney, bilateral renal tumors, or moderate/severe chronic kidney
disease (ChKD)2. The goal of partial nephrectomy is complete excision of potentially malignant
tissue without malignant cells at the border of the surgical specimen, with maximum preservation
of nearby normal renal parenchyma.It is known that nephron sparing surgery is preferred for T1a
and T1b, or when the tumor is limited in kidneys and not greater than 7 cm.In this case, the tumor
has passed T1 staging, it belonged to T2 staging .We succeeded doing the “nephron sparing
surgery”, saving less than half of the kidney. The approach to a SRM( small renal masses) is
based on tumor size, stage, and location.Most NSS requires renal vessel occlusion during the
excision, and renal tubular tissue is particularly sensitive to ischemia; the WIT ( warm ischemia
time ), therefore, should be minimized. Damage to renal tubular tissue is directly related to WIT.
Although the upper limit of WIT is debatable, a limit of 20 minutes is a generally accepted
guideline.The kidney can be approached with traditional “open” surgery or laparoscopically. For
SRMs appropriate for NSS, open partial nephrectomy represents the gold standard. This approach
has the most data regarding oncologic and renal function outcomes, with long-term cancerspecific survival rates exceeding 90%3. We can conclude that “nephron sparing surgery” in
specific cases can be used also for patients with T2a staging tumor, for those patients were there
is hope that they can benefit from this procedure.The patient has stayed in our clinic for ten days,
and is released in a good health condition, unfortunately the remaining renal parenchyma was not
sufficient to perform its function, because of the chronic pyelonephritis with an emphasized
hypoplasia of the other kidney ( left kidney). So the only benefit of this procedure in this patient
was that instead of doing the dialysis three times a week, he could do it two times a week.

Keywords: Nephron sparing surgery, renal carcinoma, partial nephrectomy, papillary renal cell
carcinoma.

Introduction
The incidence of kidney cancer continues to increase with the growth of the world population
age (4). Today, RCC accounts for 3% of adult tumors, and the highest incidence ranges between
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50 and 70 years. In the European Union, almost every year, 20,000 new patients with kidney
kidney disease are discovered. It is thought that the use of ultrasound and CT is responsible for
an increased discovery of asymptomatic tumors in the early stages, which causes these tumors
not to undergo radical nephrectomies. Today most of the new tumors discovered are less than 4
cm in the time of their detection (5). Small kidney tumors have a low metastatic potential, so they
can take care of being actively or thermally ablated. Sometimes, resuscitation of the solid kidney
stones of their treatment, when they can be suspected to be malignant.
For many decades, radical nephrectomy was a gold standard for the treatment of localized renal
carcinomas, although radical nephrectomy is a risk factor for the development of chronic kidney
disease, leading to many cardiovascular diseases and lower survival (6-7).
Despite the fact that random comparative analysis of patients with partial and radical
nephrectomy in patients with normal contralateral kidneys for tumors up to 5 cm in diameter did
not show a survival advantage for partial nephrectomy (8) according to the guidelines of the
European Urology Association (EAU), however, support the use of a more conservative surgical
intervention for kidneys, whenever possible, for cT1a and b (9) tumors. Already many analyzes
show a greater efficiency and greater safety of kidney replacement interventions (10). Even now,
this type of kidney replacement intervention is in the trend and I have begun to use it extensively,
even for T2a tumors, as is the case that we will present below.
The first surgery of a renal tumor was performed by Czerny in 1887 (11). Obviously, the nephron
sparing surgery (NSS) in the past was only performed in indispensable situations, chronic kidney
failure, chronic pyelonephritis with azotemia syndrome, or renal tumors, then when a radical
nephrectomy would lead the patient to dialysis. With time and after an ever-increasing rescue
surgery experience, the number of conservative conservation interventions with choices made
and reports published on patients with small peripheral unsafe malignant lesions (12) increased.
If all the suspected tumors are treated with radical nephrectomy, a significant number of nonmalignant kidneys, they can be recovered, such as angiomyolypomas, onocytomas, cystic
nephromas and complicated cysts (13). Since 2002 we have provided partial nephrectomy for a
selected group of patients with various localized malignant and benign tumors, even as we
present, ie a cT2a, a tumor with dimensions over 7 cm,

Materials and methods
Our work is of a retrospective-perspective type, so this work has been taken in treatment, patients
undergo partial ufrectomy at the Urology Clinic, from the beginning of 2002 to November 207.
The analysis takes into account the epidemiological data age and sex, the preoperative images
were compared, compared to postoperative (Ct. Urography), histopathology and tumor size,
histopathological type and tumor graft according to Fuhrman et al.
Of the total of 137 patients being considered, 43 (31.38%) were subject to partial partial (partial)
hypertension; patients were not randomized and the indication for partial nephrectomy was the
result of case discussions at the Clinical College , with an individual's appointment of the surgeon
himself, in agreement with the patient and family, after an exhaustive discussion with them.
Twenty-eight males (65.11%) and the 15th female (34.89%) was included in our treatment, with
an average age of 48 years, ranging from 22 to 73 years. The blood analyses of these patients
resulted from the normal ones to those of an easy anemia, while urea and creatinine, to a heavy
azotemia, as is the case of the patient we will be presenting. Most tumors were discovered by
chance during ultrasound examination or Ct. for completely other problems, from symptoms that
had little to do with kidney disease. From all cases identified with localized kidney cancer, most
of them were first identified with ultrasound, 32; 7 with ct. and 4 with MRI. The average tumor
diameter of 3.9 cm, while ours we are describing, exceeded 8 cm in height. Of all localized
tumors, most of them were found in the upper pole, 21 of them, 19, in the lower and third poles,
were found middle of kidney.
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Results and Discussion
In all cases, the intervention was performed with a lumbotomy, often with the 12th rib, with the
opening to the half of the abdomen of the respective side, going through the layers to the
corresponding the flank l loge. After the opening of the Gerota s fascia, we release the kidney
from the entire perirenal tissue, exposing the entire kidney, and then approaching the tumor by
exposing the renal pedicles and by performing the clamping of the same ("hot ischemia") to work
on a bloodless ground, given that tumor removal, limited to 2mm from tumor bones, will not last
more than 20 minutes. It's been a great deal in the case that we are showing you a right kidney
tumor with size over 8 cm, or 8.5 cm. (T2b-fig. 1), in a patient who is in dialysis, due to chronic
pyelonephritis and contralateral kidney hypoplasia. During the intervention after the tumor has
been completely removed (Fig.2), we make suture of the calyxes (sealing the calyxes) and closing
the kidneys with the sutures of the mattress and the sebaceous tissue as suture supporters (Fig.
3). After closing the operator wound according to the layers, we put a drain into the flank lodge.
The patient wakes up in the operating room and the intervention goes smoothly.
The patient is released at home after ten days, and before we release to the home, we make an
ultrasound examination (Fig. 4) and we see a kidney with a good, but insufficient to relieve the
patient from the dialysis. However, the patient has another benefit, in spite of the chances of a
longer survival, going twice a week instead of three times a week, before the intervention.
The pathological examination outcome, resulted in papillary carcinoma of clear kidney cells,
pT2a.
The patient, even nine months after the operation, has a general stable condition without signs of
recurrence and goes to dialysis twice a week.
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Figure 1. A right kidney tumor.

Figure 2. Completely removed tumor.
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Figure 3. Suture of the calyxes (sealing the calyxes) and closing the kidneys.
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Figure 4. Ultrasound examination, before patient goes home.
Partial nephrectomy, as a standardized method for solid localized tumors, all over the developed
world, has a good standardization in us, thanks to the urology experience and the loyal pursuits
of the EAU guidelines, which for most of our urologists now are mandatory. Partial nephrectomy
(NSS), in terms of treatment and prognosis, is now almost the same as that of radical
nephrectomy. We are living in the mini-invasive surgery time , laparoscopy, and mini-invasive
interventions assisted by the robot (14), radical nephrectomies are almost standard to all
urologists living in developed countries, but not of countries that have an economic stagnation,
and of course technological, which has already become addicted to medicine and can be talked
to a contemporary and advanced physician. However, partial salvaging nephrectomy has not yet
become the standard of mini-invasive surgery, because it also depends on the indigenous
individual skills, from surgeon-urologist. However, in the hands of a skilled surgeon, it is already
a golden standard with all the advantages that offers minimal invasive surgery and the patient as
a subject. Nephron sparing surgery (NSS) in renal cell cancers, remains the elective treatment for
those patients, who would have to undergo a surgical procedure, however the duration of partial
nephrectomy is compared with the ablation of cT1 renal masses, and it is shown that both
procedures have a similar pace in the local repetition. Of course, this retrospective analysis should
be interpreted carefully because of a possible selection bias (15). Active surveillance has also
been studied in patients with small kidney masses and this approach is not associated with a
higher degree of metastatic progress, compared to ablative treatments (16). These authors
demonstrated that maintaining of the renal function was equal in active surveillance, even in
partial nephrectomy patients, meaning that partial nephrectomy is able to preserve the kidney
function, in absolute majority of patients. Partial nephrectomy of renal tumors as a new standard
for the treatment for renal tumors, is mainly due to tumors of T1a and T1b tumors, but rarely
applicable for T2a tumors, as I have established and performed. Such intervention is possible
only under the conditions of a warm ischemia (clamping the vascular pedicle(17), when the
tumor removal does not last more than 20 minutes, otherwise, in all cases when warm ischemia
(clamping the vascular pedicle) lasts more than 20 minutes, cold ischemia should be applied,

32

which lasts the time of tumor removal up to 40 minutes. When we clamping the vascular pedicle
, the use of Manitol before clamping, has been a controversial issue for quite some time, but it
has been proven that there is no benefit when the pre-clamp set by its use, and its used, no
extend the life of the kidney (18),
What should be considered during the partial purulent nephrectomy procedure consists in
cleansing the surrounding tumor area, or when it comes to tumor multifocal tumors, a cleaner
area around the tumor should be provided by resounding in a no more less than 2 mm, from the
edges of the tumor. Usually we do the cut of the tumor with the electrocution only of the surface
layer part of the resonance with the rest of the nucleus with the index finger, and if the tumor also
includes the pelvis and calyces system, then this part is harvested with electric scalpel or more
scissors and then we make suture of calyces with Vicril threads, 3.0. So, removal of the tumor as
well as the chance of showing off is combined, enucleated –resection procedures, but resulting
in a satisfactory result. Such an approach is already advocated by many other urologists (19) and
it seems that this is the best way for such intervention.
Since it has been shown that the decline in renal function after partial nephrectomy, is related to
the loss of nephrons (20), I must be careful to be more sparing, so that as little as we can get
healthy tissue, just as I have acted in all cases and even in the case that I have been exposed. It
has been mentioned that in none of the cases I have executed complete kidney nephrectomy, as
a consequence of intra and postoperative bleeding, although the literature also describes such
cases (20). Our results are supported in the careful sewing of the pelvis and calyces system. We
apply kidney drainage, with stent 6 Ch, to provide urine flow and to prevent ureteral closure,
from blood coagulant, which may compromise the entire intake. Placing a drain to drain the
kidney, we consider it a mandatory part of the intervention.

Conclusion
We may conclude that "spontaneous neuronal surgery" (CNR-NSS) in special cases can also be
used for people with tumor pT2a, for persons who are expected to benefit from this procedure,
such as in our case. The patient stays at our clinic for ten days and is released at home in good
health. However, the only benefit of this patient out of this surgical procedure was to go twice in
dialysis, instead of three times as it was before and perhaps a greater survival.
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